ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
Ligand-Driven Optimization of Iron Oxide Nanoprobes for In Vivo MRI Enhancement at Ultra-High Field.
Pelayo García-Acevedo, María Luz Alonso-Alonso, Sara Ortega-Espina, Manuel Bañobre-López, Yolanda Piñeiro, Ramón Iglesias-Rey, José Rivas
Abstract read
In one paragraphArticle in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Pelayo García-AcevedoNANOMAG Laboratory, Applied Physics Department, iMATUS Materials Institute and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.ORCID https://orcid.org/0000-0002-0103-6772 María Luz Alonso-AlonsoNeuroimaging and Biotechnology Laboratory (NOBEL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Sara Ortega-EspinaNeuroimaging and Biotechnology Laboratory (NOBEL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
Manuel Bañobre-LópezAdvanced (magnetic) Theranostic Nanostructures Lab, International Iberian Nanotechnology Laboratory, Braga, Portugal.
Yolanda PiñeiroNANOMAG Laboratory, Applied Physics Department, iMATUS Materials Institute and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Ramón Iglesias-ReyNeuroimaging and Biotechnology Laboratory (NOBEL), Clinical Neurosciences Research Laboratory (LINC), Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
José RivasNANOMAG Laboratory, Applied Physics Department, iMATUS Materials Institute and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Funding
Axencia Galega de Innovación IN606B-2024.1Instituto de Salud Carlos III CP22/00061Ministerio de Ciencia e Innovación PLEC2022-009217
6 · The paper itselfAbstract
Ultra-high-field magnetic resonance imaging (UHF-MRI, B
Indexed as
Ferric CompoundsMagnetic Iron Oxide NanoparticlesMagnetic Resonance ImagingAnimalsContrast MediaLigandsContrast MediaFerric Compoundsferric oxideLigandscontrast agentsligand exchangemagnetic contrast agentsmagnetic resonanceultra high field‐MRI
Identifiers
PMID41631453
PMCPMC12994549
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390